Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332202
Status:
COMPLETED
Last Update Posted:
2018-09-10
First Post:
2006-05-30
Brief Title:
PRELUDEStudy to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-06
Start Date Type:
None
Primary Completion Date:
2013-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2006-05-30
First Submit QC Date:
May 30 2006
Study First Post Date:
2006-06-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-09-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2013-04-30
Disp First Submit QC Date:
April 30 2013
Disp First Post Date:
2013-05-08
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2018-09-06
Last Update Post Date:
2018-09-10
Last Update Post Date Type:
ACTUAL